Biotech Values

[DewDiligence]

>given MAXY-Alpha’s hold, would you pls. update your “HCV: Most Likely to Succeed” chart?<

Good idea. Maxy-alpha probably should have been listed in a different class from Albuferon and Locteron because it is (was) an NME that entailed much higher development risk. Albuferon is just ifn bound to albumin, and Locteron is indistinguishable from ordinary ifn, according to Biolex.

I’ll post an updated table shortly.